Are pharmaceutical marketers still waiting for divine guidance from the FDA? After two different draft guidances there is still significant anxiety on the part of regulated industry to fully engage the potential of social media. This panel will address why — and what can be done about it so that industry can become social media’s First Among Equals.
Peter Pitts, CENTER FOR MEDICINE IN THE PUBLIC INTEREST
- Date:September 18, 2014
- Time:4:30 pm
- Event:Social Media & Multi-Channel Marketing For Pharma